Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tempest Therapeutics
Tempest Therapeutics Announces Up To $6 Million Private Placement
May 4, 2026
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
May 2, 2026
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
April 30, 2026
Tempest Reports Year End 2025 Financial Results and Provides Business Update
March 31, 2026
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
March 10, 2026
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
March 9, 2026
←
Previous Page
1
2